Social Context: Plan B and Emergency Contraception is based on the following sources:
“Trends in Teen Pregnancy and Childbearing,” Office of Adolescent Health, August 28, 2015; Kathryn Kost
and Stanley Henshaw, “U.S. Teenage Pregnancies, Births and Abortions, 2010: National and State Trends
by Age, Race and Ethnicity,” Guttmacher Institute, May 2014; Susan Perry, “Rape, Pregnancy, Statistics
and the Ignorance of Some Politicians,” MinnPost, June 13, 2013; Pam Belluck, “Drug’s Nickname May
Have Aided Politicization,” The New York Times, June 5, 2012; A. Glasier, S. Cameron, P. Fine, et al.,
“Ulipristal Acetate versus Levonorgestrel for Emergency Contraception: A Randomized Non-inferiority Trial
and Meta-analysis,” The Lancet 375 (2010): 555–562; Mayo Clinic Staff, “Morning–After Pill,” Mayo Clinic,
April 14, 2015; Pam Belluck, “Science at Issue in Debate on Morning-After Pill,” The New York Times, June
5, 2012; Pam Belluck and Erik Eckholm, “Religious Groups Equate Abortion with Some Contraceptives,”
For further background, also see the following New York Times articles: by Gina Kolata, “A
Contraceptive Clears a Hurdle to Wider Access,” December 17, 2003; by Gardner Harris, “U.S. Rules
Morning-After Pill Can’t be Sold Over the Counter,” May 7, 2004; “Morning-After Pill Ruling Defies Norm,”
May 8, 2004; “FDA’s Role in Delaying Contraceptive is Criticized,” March 17, 2005; “FDA Puts Off Decision
on Sale of Birth Control,” August 26, 2005; “Official Quits on Pill Delay at FDA,” September 1, 2005;
“Report Details FDA Rejection of Next-Day Pill,” November 14, 2005; “FDA Gains Accord on Wider Sales
of Next-Day Pill,” August 9, 2006; and “F.D.A. Approves Broader Access to Next-Day Pill,” August 25,
2006; “Panel Recommends Approval of After–Sex Pill to Prevent Pregnancy ELLA,” June 17, 2010; “F.D.A.
Approves 5-Day Emergency Contraceptive,” August 13, 2010; by Stephanie Saul, “FDA. Shifts View on
Next-Day Pill,” August 1, 2006; and by Pam Belluck, “Abortion Qualms on Morning-After Pill May Be
Case Presentation: The “Abortion Pill”—The Rise of Medication Abortion draws on Heather
D. Boonstra, “Medication Abortion Restrictions Burden Women and Providers—and Threaten U.S. Trend
Toward Very Early Abortion,” Guttmacher Policy Review 16, no. 1 (2013); Emily Bazelon, “The Dawn of the
Post-Clinic Abortion,” The New York Times Magazine, August 28, 2014; Mary Gatter, Kelly Cleland, and
Deborah L. Nucatola, “Efficacy and Safety of Medical Abortion Using Mifepristone and Buccal Misoprostol